Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
Medtronic
The question of whether Medtronic is a nicher depends upon perspective. When a single focus is upon each single product, they can be said to appeal to niche markets. The external and implantable pacemakers and related products for example would appeal to the market of heart sufferers and their caregivers. As the company expanded, they were able to develop other products for both heart conditions and other ailments of the body. Each product individually appeals to the niche for the specific condition that they manage or cure.
When the perspective is widened to include all the products that Medtronic offers, the company can still be viewed to some extent as a nicher. The products appeal to patients and medical professionals who are concerned with specific conditions. However, this point can be debated with the counter view that the wider market means that it is no longer a niche. Indeed, the many therapies offered include a wide range of illnesses, which might imply that the company's products now appeal to a general medical market rather than just a niche.
The question can also be considered from a historical perspective. The company's first niche product was its external pacemaker. Much lighter and smaller than the existing model, it appealed particularly to the pre-adult heart patient population. With the development of its implantable model, the company was a nicher in the true sense of the world, appealing to the heart patient market and the medical professionals working with heart-related conditions.
As Medtronic's product range widened, its appeal to a single niche became divided among several markets. If an overall perspective is therefore taken, it can be said that Medtronic's products appeal to a range of markets within the wider category of the medical profession. When seen in a collective sense, the product range is not so much focused upon a niche as it is upon the main medical market, whereas each specific product on the other hand does appeal to a niche.
Source
Medtronic. www.medtronic.com
Background In June, 2014, the world's #2 maker of medical devices, Medtronic, agreed to buy Covidien, a smaller company in the same industry. The deal was valued at $42.9 billion, and it was a cash and stock deal. The deal was done at a 29% premium over Covidien's June 13, 2014 closing price. The deal was described by Medtronic's CEO as a "strategic and operational alignment" and there were immediate benefits
Nic.in/ibi/t02/i6/ibit02i6p379.pdf)." Fewer injections. Flexible eating and schedule. Match insulin doses precisely to need. Correct the Dawn Phenomenon. Less hypoglycemia and hypoglycemia unawareness. Reduces insulin quickly for exercise. Provide better health through better control (http://www.diabetesnet.com/diabetes_technology/insulin-pumps-advanced.html)." Problems With Pumps While the insulin pump has many advantages, it is not immune to problems. One of its basic problems "is the potential alteration of the administered insulin by motion, contact with pump surfaces and changes in temperature. Insulin forms aggregated macromolecules that have
Q3: Compare FDA Form 483 to an FDA "warning letter." The intention of a Form 483 is to teach, not to punish, according to the FDA. After it conducts an inspection, the FDA prepares an internal briefing. However, it also presents a Form 483 in private to the establishment which lists all of the institution's violations of FDA regulations (Gyi et al. 2001). This is to better enable the facility to
side-listed positions possible. There are also questions with regard to the nature of e-commerce queries and the trends in sponsored links that shed light on their effectiveness overall. Comparing Literature Reviews In both articles, the literature reviews are thorough and very well organized. Starting with (Jansen 2007) the depth of literature review to the cause -- and effect level of the analysis is impressive. The researchers who completed the analysis in
Covidien Pad Research There are a number of major concerns when it comes to the residents of rehabilitation centers, nursing homes or any other similar facilities that house people of higher age and/or that otherwise have toileting issues. While the management, supervisors and nurses (among others) of those facilities take great care to ensure that residents are using the toilet as they need to and assisting them with the same as
Taken in isolation, some of the new, minimally-invasive procedures are less expensive by far, when analyzed on a procedure-by-procedure basis, than previous significant surgical interventions, as demonstrated below: Procedure Cost Estimated duration of 'cure' CABG 5-7 years PCI (percutaneous coronary intervention 3-5 years Based on the above analysis, it would appear to be clear that a PCI is more cost-effective than CABG procedures. This may not be true when all costs are considered, however. The logic of